SCHEMBL2013227

SCHEMBL2013227

CC(C)(C)OC(=O)N[C@]1(Cc2ccccc2)CNC[C@H]1c1ccc(F)c(F)c1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA7 P43166 1/20 0.34
CA14 Q9ULX7 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM1A O60341 3/20 0.33
ADRA1D P25100 3/20 0.33
ADRA1A P35348 3/20 0.33
ADRA1B P35368 3/20 0.33
GRIN2B Q13224 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
AKT1 P31749 3/20 0.33
CTSL P07711 2/20 0.32
CTSB P07858 2/20 0.32
CTSS P25774 2/20 0.32
EPHX2 P34913 1/20 0.32
ACE P12821 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016334 0.92 SLC6A2 (0.39) KMT2AL3MBTL1ADRA1DADRA1AADRA1B
SCHEMBL2012019 0.87 KDM1A (0.39) CA12CA1CA7CA14KMT2A
SCHEMBL2226908 0.87 KMT2A (0.36) CA12CA1CA7CA14KMT2A
SCHEMBL1720734 0.86 KMT2A (0.40) CA12CA1CA7CA14KMT2A
SCHEMBL462003 0.85 IDO1 (0.36) CA12CA1CA7CA14KMT2A
SCHEMBL459500 0.85 HTT (0.34) CA12CA1CA7CA14KMT2A
SCHEMBL457233 0.84 KMT2A (0.32) CA12CA1CA7CA14KMT2A
SCHEMBL459152 0.84 CTSS (0.36) CA12CA1CA7CA14KMT2A
SCHEMBL462095 0.83 RORC (0.36) CA12CA1CA7CA14KMT2A
SCHEMBL1726610 0.79 KMT2A (0.37) CA12CA1CA7CA14KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513084-A1 PYRROLIDINE DERIVATIVES AS NK - 3 RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2012-10-24 EP disclosed
WO-2011073160-A1 PYRROLIDINE DERIVATIVES AS NK - 3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-06-23 WO disclosed